Codes / ICD10CM / C44.719

C44.719 Basal cell carcinoma of skin of left lower limb, including hip

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Basal cell carcinoma of skin of left lower limb, including hip.

Summary

This condition refers to a malignant growth of basal cell carcinoma (BCC) on the skin of the left lower limb, including the hip. BCC is the most common type of skin cancer, arising from basal cells in the epidermis. It typically grows slowly and is often localized, though it can invade surrounding tissues if left untreated.

Causes

The primary cause is genetic mutations in basal skin cells, often triggered by chronic ultraviolet (UV) radiation exposure from sunlight or tanning devices. Other factors, such as environmental exposures or genetic predispositions, may contribute, but UV damage is the most significant risk factor.

Risk Factors

  • UV Exposure: Prolonged or intense sunlight exposure without protection.
  • Skin Type: Fair skin with less melanin, which offers less natural UV defense.
  • Age: Higher incidence with advancing age.
  • Prior Skin Cancers: Personal or family history of skin malignancies.
  • Immunosuppression: Weakened immune systems may increase susceptibility.

Symptoms

  • Visible Growths: Pearly or waxy bumps, often with visible blood vessels.
  • Texture Changes: Smooth or ulcerated areas that may bleed or crust.
  • Discoloration: Pink, red, or brownish lesions that may resemble sores.
  • Slow Growth: Gradual enlargement over time.

Diagnosis

Diagnosis typically involves a clinical examination of the lesion, followed by a skin biopsy to confirm the presence of BCC. Dermoscopy may be used to assess the lesion's characteristics, and imaging studies (e.g., MRI or CT) may be ordered if deeper tissue invasion is suspected.

Treatment Options

Treatment depends on the size, location, and depth of the carcinoma. Common options include surgical excision, Mohs micrographic surgery, cryotherapy, topical medications (e.g., imiquimod), or radiation therapy for cases where surgery is not feasible.

Prognosis and Follow-Up

With early detection and appropriate treatment, the prognosis is excellent, as BCC rarely metastasizes. Regular follow-up appointments are recommended to monitor for recurrence or new lesions, especially in high-risk individuals.

Complications

If left untreated, BCC can invade surrounding tissues, leading to disfigurement or functional impairment. Rarely, it may cause nerve damage or secondary infections. Metastasis is uncommon but possible in advanced cases.

Lifestyle & Prevention

  • Sun Protection: Use broad-spectrum sunscreen, wear protective clothing, and avoid peak sun hours.
  • Skin Checks: Perform regular self-examinations and consult a dermatologist for annual screenings.
  • Avoid Tanning Beds: Minimize exposure to artificial UV sources.
  • Healthy Habits: Maintain a balanced diet and avoid smoking, which may increase skin cancer risk.

When to Seek Professional Help

Seek medical attention if you notice new or changing skin lesions, persistent sores that do not heal, or unusual growths on the left lower limb. Early evaluation is critical for effective treatment.

Tips for Medical Coders

When coding for C44.719, ensure the documentation specifies the left lower limb, including the hip, to accurately reflect the site. Verify that the diagnosis aligns with clinical findings and that any biopsies or treatments are appropriately documented to support the code assignment.

Book a walkthrough

C44.719 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.